Large companies are benefiting from a tax change they fought 

Tech and pharmaceutical companies say that a recently enacted tax law is reducing their rates, even though corporate executives fought Congress to reverse the policy, The Wall Street Journal reports.   The provision requires companies to spread their deductions for research expenses over at least five years instead of writing them off immediately. As a result,